Richard Aldrich

Richard Aldrich

Signal active

Co - Founder & Partner

Bio

Richard Aldrich is a co-founder of Concert Pharmaceuticals and has served as our Chairman of the Board since May 2006.

Richard Aldrich co-founded Longwood Founders Fund in 2010, a fund that starts and invests in biotechnology companies, and currently serves as a Partner in the firm.

Prior to Longwood, he was General Partner of RA Capital, a biotech investment fund he founded in 2001.

Richard Aldrich was a co-founding employee of Vertex Pharmaceuticals where he held the position of Senior Vice President and Chief Business Officer and managed all commercial and operating functions from 1989 to 2001.

Prior to joining Vertex, Richard Aldrich held several management positions at Biogen Inc. In addition to Concert, Richard Aldrich has co-founded and helped build several successful biotech companies including Sirtris Pharmaceuticals and Alnara Pharmaceuticals.

Richard Aldrich received his undergraduate degree from Boston College, and an MBA from the Amos Tuck School at Dartmouth College.

Location

N/A

Social

Primary Organization

Longwood Fund

Longwood Fund

Founded

2010

Investment

60

Lead investment

11

Exits

16

Employees

11-50

Industry

Venture Capital, Finance

Jobs history

2

Axial Biotherapeutics

Board Member

Invalid date - Current

Director

2017 - 2022

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Richard Aldrich is the Co - Founder & Partner at Longwood Fund. With a background in Venture Capital, Richard Aldrich has a rich history of leadership and innovation. Richard Aldrich studied MBA unknown @ Tuck School of Business at Dartmouth College. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

Zachary Weiner

Zachary Weiner

CoFounder, President

Joon Sung Park

Joon Sung Park

No designation

Mitch Lasky

Mitch Lasky

Partner

Greg Harper

Greg Harper

Chief Operating Officer

Bob Meese

Bob Meese

Chief Business Officer

Stephen Lim

Stephen Lim

Co-Founder and Product Director

Investment portfolio

Richard Aldrich has made 2 investments. Their Latest investment was Seed Round - Altera on May 08, 2024

Number of investment

2

Number of exits

0

Personal investment

2

Annouced DateOrganization NameFunding RoundMoney Raised
Jan 01, 2024
Altera Altera
Pre Seed Round - Altera
2.0M
May 08, 2024
Altera Altera
Seed Round - Altera
9.0M

Partner investment

2

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
Sep 10, 2014
Colorescience Colorescience
Series B - Colorescience
Colorescience Longwood Fund
15.0M
Oct 13, 2021
Axial Biotherapeutics Axial Biotherapeutics
Series C - Axial Biotherapeutics
Axial Biotherapeutics Longwood Fund
37.3M

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.